53 related articles for article (PubMed ID: 28504662)
1. Iron overload in the HCT patient: a review.
Tenneti P; Chojecki A; Knovich MA
Bone Marrow Transplant; 2021 Aug; 56(8):1794-1804. PubMed ID: 33782548
[TBL] [Abstract][Full Text] [Related]
2. Advances in the understanding of poor graft function following allogeneic hematopoietic stem-cell transplantation.
Chen J; Wang H; Zhou J; Feng S
Ther Adv Hematol; 2020; 11():2040620720948743. PubMed ID: 32874483
[TBL] [Abstract][Full Text] [Related]
3. Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation.
Malki MMA; Song JY; Yang D; Cao T; Aldoss I; Mokhtari S; Dadwal S; Marcucci G; Karanes C; Snyder D; Nademanee A; Forman SJ; Nakamura R; Pullarkat V
Biol Blood Marrow Transplant; 2020 Sep; 26(9):1697-1703. PubMed ID: 32534103
[TBL] [Abstract][Full Text] [Related]
4. Infections in Myelodysplastic Syndrome in Relation to Stage and Therapy.
Leone G; Pagano L
Mediterr J Hematol Infect Dis; 2018; 10(1):e2018039. PubMed ID: 30002795
[TBL] [Abstract][Full Text] [Related]
5. Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection.
Ohmoto A; Fuji S; Miyagi-Maeshima A; Kim SW; Tajima K; Tanaka T; Okinaka K; Kurosawa S; Inamoto Y; Taniguchi H; Fukuda T
Bone Marrow Transplant; 2017 Aug; 52(8):1201-1203. PubMed ID: 28504662
[No Abstract] [Full Text] [Related]
6. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
Mahindra A; Bolwell B; Sobecks R; Rybicki L; Pohlman B; Dean R; Andresen S; Sweetenham J; Kalaycio M; Copelan E
Br J Haematol; 2009 Aug; 146(3):310-6. PubMed ID: 19508292
[TBL] [Abstract][Full Text] [Related]
7. Clinical and microbiological impact of long-term discontinuation of fluoroquinolone prophylaxis in haematological patients with prolonged profound neutropenia.
Verlinden A; Schroyens WA; Gadisseur AP
Eur J Haematol; 2021 Sep; 107(3):377-379. PubMed ID: 34018235
[No Abstract] [Full Text] [Related]
8. [The role of stromal and hematopoietic tissue interaction in pathology of hematopoiesis].
Morozova VT
Klin Lab Diagn; 2003 Aug; (8):33-6. PubMed ID: 14524126
[No Abstract] [Full Text] [Related]
9. Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS.
Leitch HA; Buckstein R; Zhu N; Nevill TJ; Yee KWL; Leber B; Keating MM; St Hilaire E; Kumar R; Delage R; Geddes M; Storring JM; Shamy A; Elemary M; Wells RA
Leuk Res; 2018 Nov; 74():21-41. PubMed ID: 30286330
[TBL] [Abstract][Full Text] [Related]
10. Predicting the presence or absence of ringed sideroblasts in patients suspected of having a myelodysplastic syndrome and increased iron stores: a simple observation.
Dorion RP; Alomari M; Wood GC
Leukemia; 2001 Nov; 15(11):1793-5. PubMed ID: 11681424
[No Abstract] [Full Text] [Related]
11. Increased Bone Marrow Iron Scores Are Strongly Correlated With Elevated Serum Ferritin Levels and Poorer Survival in Patients With Iron Overload That Underwent Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience.
Sivgin S; Nazlim S; Zararsiz G; Baspinar O; Kaynar L; Deniz K; Cetin M; Unal A; Eser B
Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):582-587. PubMed ID: 27769559
[TBL] [Abstract][Full Text] [Related]
12. Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation.
Sivgin S; Baldane S; Deniz K; Zararsiz G; Kaynar L; Cetin M; Unal A; Eser B
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S10-8. PubMed ID: 27521305
[TBL] [Abstract][Full Text] [Related]
13. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors.
Young JH; Logan BR; Wu J; Wingard JR; Weisdorf DJ; Mudrick C; Knust K; Horowitz MM; Confer DL; Dubberke ER; Pergam SA; Marty FM; Strasfeld LM; Brown JWM; Langston AA; Schuster MG; Kaul DR; Martin SI; Anasetti C;
Biol Blood Marrow Transplant; 2016 Feb; 22(2):359-370. PubMed ID: 26409243
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
